混合型肝细胞-胆管癌的MRI特征
本文综述了罕见肝脏肿瘤混合型肝细胞-胆管癌(cHCC-CCA)目前报道的MRI表现。混合型强化模式特异度最高,表现为病灶内渐进性强化区、动脉期强化伴廓清区以及动脉期强化无廓清和/或乏血供区的组合。肿瘤标志物可能有助于鉴别,尤其当影像表现类似单纯HCC或iCCA时。
要点
- 混合型强化模式特异度最高:渐进性强化、动脉期强化伴廓清、动脉期强化无廓清和/或乏血供区并存。
- 影像表现可类似单纯HCC或iCCA,肿瘤标志物可能有助于鉴别。
- 瘤内异质性可致活检病理诊断困难,标本需包含两种组织学成分。
核心结论
- cHCC-CCA的MRI混合型强化模式特异度最高;肿瘤标志物可能有助于鉴别影像上类似单纯HCC或iCCA的病例;瘤内异质性可导致活检病理诊断困难。
研究设计与样本
- 综述,汇总目前关于cHCC-CCA的MRI表现的研究。
关键影像表现/征象
- 混合型模式表现为病灶内渐进性强化区、动脉期强化伴廓清区、动脉期强化无廓清和/或乏血供区的组合。
- 影像表现可类似单纯HCC或iCCA。
诊断标准与关键数值
- 混合型强化模式在目前研究中显示最高特异度,定义为渐进性强化、动脉期强化伴廓清、动脉期强化无廓清和/或乏血供区的组合。
临床应用与阅片要点
- 阅片时注意识别混合型强化模式,该模式特异度最高。
- 当影像表现类似单纯HCC或iCCA时,肿瘤标志物可能有助于鉴别。
- 活检标本需包含两种组织学成分以避免因瘤内异质性导致误诊。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a rare liver tumor which has a more aggressive behavior and worse survival outcome than hepatocellular carcinoma (HCC), with a prognosis similar to that of intrahepatic cholangiocarcinoma (iCCA). With limited literature on the appearance of this tumor on MRI, it remains a diagnostic challenge. In this review, we looked at the currently described MRI findings in this uncommon entity. Based on studies conducted to date, a mixed pattern at imaging has demonstrated the highest specificity, seen as a combination of areas showing progressive enhancement of the lesion, arterial enhancement with washout, and areas of arterial enhancement without washout and/or hypovascularity. Tumor markers may aid in identification, particularly in cases where the imaging appearance mimics that of isolated HCC or iCCA. Intratumoral heterogeneity leads to difficulties with pathologic diagnosis from sampling due to the possibility of an incorrect diagnosis if the biopsy specimen does not contain adequate tissue comprising both histologic components.
引用
- Majeed NF, Macey M, Amirfarzan MB, et al. MRI features of combined hepatocellular-cholangiocarcinoma. Abdom Radiol (NY). 2024. PMID: 39031181. doi:10.1007/s00261-024-04476-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。